Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results from the PARTNER Trial

BACKGROUND: Transcatheter Aortic Valve Replacement (TAVR) has emerged as a less invasive option for valve replacement for high-risk patients with severe aortic stenosis. However, not all patients derive a mortality or quality of life (QoL) benefit from TAVR. As such, we sought to build and validate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Arnold, Suzanne V., Reynolds, Matthew R., Lei, Yang, Magnuson, Elizabeth A., Kirtane, Ajay J., Kodali, Susheel K., Zajarias, Alan, Thourani, Vinod H., Green, Philip, Rodés-Cabau, Josep, Beohar, Nirat, Mack, Michael J., Leon, Martin B., Cohen, David J.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4198056/
https://ncbi.nlm.nih.gov/pubmed/24958751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.113.007477
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars